FdaApplication

BLA 761181

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRegeneron Pharmaceuticals, Inc.
application_typeBLA
approval_date2021-02-11

Products (2)

ProductActive ingredientStrengthDosage form
EVKEEZAEVINACUMAB-DGNB1,200MG/8ML (150MG/ML)SOLUTION;INJECTION
EVKEEZAEVINACUMAB-DGNB345MG/2.3ML (150MG/ML)SOLUTION;INJECTION

2 products